Balance Sheet Components (Tables)

6 Months Ended

Jun. 30, 2026

Balance Sheet Related Disclosures [Abstract]

Schedule of Inventory

Inventory consisted of the following:


		June 30,				December 31,
(In thousands)		2026				2025
Raw materials		$	18,724			$	16,330
Work-in-process			15,123				17,871
Finished goods			5,121				4,971
Total inventory		$	38,968			$	39,172

Schedule of Other Accrued Liabilities

Other accrued liabilities consisted of the following:


		June 30,				December 31,
(In thousands)		2026				2025
Accrued contract manufacturing expenses		$	9,322			$	8,220
Accrued clinical and research expenses			150				185
Accrued professional services			4,979				5,845
Current portion of lease liabilities			712				418
Royalty obligation payable			4,148				3,690
Current portion of deferred royalty obligations			6,302				8,124
Accrued license fees and royalties			2,102				1,964
Other			898				1,022
Total other accrued liabilities		$	28,613			$	29,468

Schedule of Other Long-term Liabilities

Other long-term liabilities consisted of the following:


		June 30,				December 31,
(In thousands)		2026				2025
Long-term portion of deferred royalty obligation		$	55,280			$	54,104
Long-term portion of lease liabilities			10,491				10,868
Other			1,505				1,119
Total other long-term liabilities		$	67,276			$	66,091